Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease-Reference-Cited by-同舟云学术

Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease

Published:2019-01-08 Issue:2 Volume:139 Page:243-255
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Tsilingiri Katerina¹,de la Fuente Hortensia²³,Relaño Marta¹,Sánchez-Díaz Raquel¹³,Rodríguez Cristina⁴³,Crespo Javier⁴³,Sánchez-Cabo Fátima⁵,Dopazo Ana⁶,Alonso-Lebrero José L.²,Vara Alicia²,Vázquez Jesús⁷,Casasnovas José M.⁸,Alfonso Fernando⁹,Ibáñez Borja¹⁰¹¹³,Fuster Valentín¹¹²,Martínez-González José¹³³,Martín Pilar¹³,Sánchez-Madrid Francisco¹²³

Affiliation:

1. Vascular Pathophysiology Area (K.T., M.R., R.S.-D., V.F., P.M., F.S.-M.), Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

2. Department of Immunology (H.d.L.F., J.L.A.-L., A.V., F.S.-M.), Instituto de Investigación Sanitaria Hospital de la Princesa, IIS-IP, Madrid, Spain.

3. CIBER de Enfermedades Cardiovasculares, Madrid, Spain (H.d.L.F., R.S.-D., C.R., J.V., B.I., J.M.-G, P.M., F.S.-M.).

4. Institut de Recerca del Hospital de la Santa Creu i Sant Pau-Programa ICCC, IIB-Sant Pau, Barcelona, Spain (C.R., J.C.).

5. Bioinformatics Unit (F.S.-C.), Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

6. Genomics Unit (A.D.), Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

7. Proteomics Unit (J.V.), Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

8. Centro Nacional de Biotecnología, Madrid, Spain (J.M.C.).

9. Department of Cardiology (F.A.), Instituto de Investigación Sanitaria Hospital de la Princesa, IIS-IP, Madrid, Spain.

10. Myocardial Pathophysiology Area (B.I.), Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

11. IIS-Fundación Jiménez Díaz University Hospital, Madrid, Spain (B.I.).

12. Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (V.F.).

13. Instituto de Investigaciones Biomédicas de Barcelona, IIB-Sant Pau, Spain (J.M.-G.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Interleukin-1 Beta as a Target for Atherosclerosis Therapy

2. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

3. Proatherogenic Conditions Promote Autoimmune T Helper 17 Cell Responses In Vivo

4. The inflammatory response in myocardial injury, repair, and remodelling

5. Natural regulatory T cells control the development of atherosclerosis in mice

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulation of NOR-1 in calcified human vascular tissues: impact on osteogenic differentiation and calcification;Translational Research;2024-02

2. CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer;ImmunoTargets and Therapy;2024-01

3. The CXCL10-CXCR3 axis plays an important role in Kawasaki disease;Clinical and Experimental Immunology;2023-11-11

4. Inflammation contributes to the pathogenic effects of subclinical atherosclerosis;European Heart Journal;2023-11-04

5. Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study;European Heart Journal;2023-06-20